Alginate-PVPI Composite for Controlled Release
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current medical devices using povidone-iodine (PVPI) face limitations due to its quick absorption by open wounds, leading to toxicity issues and restricted surgical applications, and existing wound dressings often employ non-biodegradable polymers like polyethylene glycol (PEG).
Innovation Solution
A composite material comprising a matrix of alginate with dispersed PVPI, providing a controlled release system for PVPI, including self-supporting films, microcapsules, and biodegradable suture threads, which utilize sodium or calcium alginate with glycerol as a plasticizer to achieve synergistic antiseptic and healing effects without increasing glycemic indices.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If PVPI is applied directly to open wounds for irrigation, then bactericide and fungicide properties are achieved, but quick absorption causes severe toxicity problems
Solution Approach 1:
The patent uses an alginate matrix as an intermediary carrier to deliver PVPI to wounds. The alginate controls the release rate of PVPI, preventing rapid absorption and toxicity while maintaining antimicrobial efficacy. This mediator system allows the active ingredient to be delivered safely over time rather than all at once.
Solution Approach 2:
The patent changes the physical state and release parameters of PVPI by incorporating it into an alginate matrix. This transforms PVPI from a rapidly absorbed liquid solution into a controlled-release system where the concentration and release rate are modulated by the alginate structure, thereby reducing peak toxicity while maintaining therapeutic effect.
2Reliability
If PVPI is combined with PEG for wound dressings, then PVPI delivery is improved, but PEG is non-biodegradable
Solution Approach 1:
The patent creates a composite material system combining alginate with PVPI. Alginate is a natural, biodegradable polysaccharide that forms a suitable matrix for PVPI delivery. This composite approach replaces the non-biodegradable PEG system with a biodegradable alternative that maintains delivery functionality while adding environmental and clinical benefits.
Solution Approach 2:
The patent changes the material composition parameter from synthetic PEG to natural alginate, thereby transforming the biodegradability property from negative to positive while maintaining the PVPI delivery capability. This parameter change in the base material achieves both delivery reliability and biodegradability.
3Duration of action of moving object
If repeated applications of PVPI irrigation are performed, then wound treatment is maintained, but cumulative toxicity increases
Solution Approach 1:
The patent applies preliminary action by incorporating PVPI into the alginate matrix before application. This pre-prepared controlled-release system ensures that subsequent applications or prolonged contact do not result in cumulative toxicity, as the release rate is inherently limited by the matrix structure from the outset.
Solution Approach 2:
The alginate matrix serves as a protective intermediary that mediates between repeated PVPI applications and the wound tissue. It buffers the cumulative effect by controlling release rates, allowing prolonged treatment duration without proportional increase in toxicity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The alginate-PVPI composite materials offer controlled release of PVPI, reducing toxicity, enhancing wound healing, and providing effective antimicrobial protection with biodegradability, suitable for internal and external wound treatments, including diabetic ulcers, while minimizing the risk of infection and eliminating the need for suture removal.
Implementation Method 1
PVPI is known for its iodo-phor properties, i.e., as a substance acting as a vehicle or solubilizer for iodine and which is able to release into solution small amounts of free iodine
Implementation Method 2
composite materials comprising, a matrix of alginate in which the iodopovidone complex is dispersed
Implementation Method 3
biodegradable materials suitable for a controlled release of PVPI
Data Source
Figure 1(a)~1(e)
Figure 2A~3
AI summary
A composite material for the production of a medical device having an antiseptic action, consisting of or comprising a matrix of alginate in which the complex of iodopovidone is dispersed. The composite material is used particularly for the production of films, micro- capsules, and suture threads with iodine controlled release.